An “occlusive thrombosis-on-a-chip” microfluidic device for investigating the effect of anti-thrombotic drugs

Cardiovascular disease remains one of the world's leading causes of death. Myocardial infarction (heart attack) is triggered by occlusion of coronary arteries by platelet-rich thrombi (clots). The development of new anti-platelet drugs to prevent myocardial infarction continues to be an active...

Descripción completa

Detalles Bibliográficos
Autores principales: Berry, Jess, Peaudecerf, François J., Masters, Nicole A., Neeves, Keith B., Goldstein, Raymond E., Harper, Matthew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547327/
https://www.ncbi.nlm.nih.gov/pubmed/34523623
http://dx.doi.org/10.1039/d1lc00347j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547327/
https://www.ncbi.nlm.nih.gov/pubmed/34523623
http://dx.doi.org/10.1039/d1lc00347j

Ejemplares similares